SEC Company Response from 20 (AIDX) — Jul 15, 2020

20/20 Biolabs, Inc. (AIDX) (CIK 0001139685)
Date: July 15, 2020 · CIK: 0001139685 · Accession: 0001213900-20-017539

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 024-11056

Date

July 15, 2020

Author

Form

CORRESP

Company

20/20 Biolabs, Inc. (AIDX) (CIK 0001139685)

Letter

Offering Statement on Form 1-A Post-Qualification Amendment No. 1 Filed July 8, 2020 File No. 024-11056

Dear Ms. Wirth:

We understand that the staff of the U.S. Securities and Exchange Commission (the “Commission”) has completed its review of the Post-Qualification Amendment No. 1 to Offering Statement on Form 1-A (the “Offering Statement”) of 20/20 GeneSystems, Inc. (the “Company”) and we hereby request that the Commission approve the qualification of the Offering Statement as of 4:00 PM Eastern Time on Friday, July 17, 2020.

We request that we be notified of such qualification by a telephone call to Mr. Louis A. Bevilacqua at (202) 869-0888 ext. 100. We also respectfully request that a copy of the written order from the Commission verifying the date and time of qualification of the Company’s Offering Statement be sent to Louis A. Bevilacqua via email at lou@bevilacquapllc.com

Sincerely,
20/20 GeneSystems, Inc.

Show Raw Text

CORRESP
1
filename1.htm

20/20 GeneSystems, Inc.

9430 Key West Ave.

Rockville, MD 20850

July 15, 2020

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attn: Cara Wirth

    Re:
    20/20 GeneSystems, Inc.

    Offering Statement on Form 1-A

    Post-Qualification Amendment No. 1

    Filed July 8, 2020

    File No. 024-11056

Dear Ms. Wirth:

We understand that the staff of the U.S. Securities
and Exchange Commission (the “Commission”) has completed its review of the Post-Qualification Amendment No. 1 to Offering
Statement on Form 1-A (the “Offering Statement”) of 20/20 GeneSystems, Inc. (the “Company”) and we hereby
request that the Commission approve the qualification of the Offering Statement as of 4:00 PM Eastern Time on Friday, July 17,
2020.

We request that we be notified of such qualification
by a telephone call to Mr. Louis A. Bevilacqua at (202) 869-0888 ext. 100. We also respectfully request that a copy of the written
order from the Commission verifying the date and time of qualification of the Company’s Offering Statement be sent to Louis
A. Bevilacqua via email at lou@bevilacquapllc.com

    Sincerely,

    20/20 GeneSystems, Inc.

    By:
    /s/ Jonathan Cohen

    Jonathan Cohen

    Chief Executive Officer

 cc: Louis A. Bevilacqua, Esq.

SecProbe.io